What is GRASTIM 300MCG/ML?
GRASTIM 300MCG/ML is an injectable medicine containing Filgrastim, a recombinant human granulocyte colony-stimulating factor (G-CSF). It stimulates the bone marrow to produce neutrophils, which are essential white blood cells that fight infections.
It is commonly used in patients with chemotherapy-induced neutropenia, bone marrow transplantation, or chronic neutropenia to reduce infection risk.
What is the use of GRASTIM 300MCG/ML?
-
To prevent or treat neutropenia caused by chemotherapy.
-
To reduce infection risk in patients with low white blood cells.
-
To mobilize hematopoietic stem cells for transplantation procedures.
Benefits of GRASTIM 300MCG/ML:
-
Boosts neutrophil counts to enhance immune defense.
-
Helps patients tolerate chemotherapy by reducing infection risk.
-
Supports faster recovery of white blood cells after chemotherapy.
-
Can be used for stem cell mobilization for transplantation.
Side Effects of GRASTIM 300MCG/ML:
-
Common: Bone or muscle pain, headache, mild fever, fatigue, injection site reactions.
-
Rare/Serious: Splenomegaly or spleen rupture, severe allergic reactions, low platelet count.
Note: Blood counts and spleen monitoring are recommended during therapy.
Dosage and Administration:
-
Administered subcutaneously or intravenously as prescribed.
-
Dose depends on body weight, type of chemotherapy, and neutrophil counts.
Reviews
There are no reviews yet.